NICE has developed a medtech innovation briefing (MIB) on point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory
NICE has developed a medtech innovation briefing (MIB) on RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease
We have temporarily withdrawn this medtech innovation briefing to update the information with regard to further research in this area.
Summary of the evidence on the risk of using broad-specturm antibiotics associated with clostridium difficile infection
NICE has developed a medtech innovation briefing (MIB) on eXroid for internal haemorrhoids
NICE has developed a medtech innovation briefing on Immunoscore for predicting risk of colon cancer relapse
NICE has developed a medtech innovation briefing (MIB) on The Insides System for managing intestinal failure